KY

Kin T. Yu

RP Rorer Pharmaceutical: 3 patents #25 of 98Top 30%
AP Aventis Pharmaceuticals: 1 patents #232 of 454Top 55%
RP Rhone-Poulenc Rorer Pharmaceuticals: 1 patents #68 of 155Top 45%
SA Sanofi: 1 patents #1,013 of 1,881Top 55%
Overall (All Time): #855,618 of 4,157,543Top 25%
6
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
8658649 Kinase inhibitor Timothy A. Gillespy, Paul Eynott, Elizabeth Allen, Asher Zilberstein 2014-02-25
6720153 Luciferase reporter bioassay of parathyroid hormone compounds Richard F. Labaudiniere, Gregg R. Crumley, Clarence C. Morse 2004-04-13
5015663 Treatment of conditions requiring enhanced oxygen availability of mammalian tissues John T. Suh, Robert G. Pendleton, Charles E. Pendley, II, Paul R. Menard, Alain B. Schreiber 1991-05-14
4948582 Treatment of conditions requiring enhanced oxygen availability to mammalian tissues John T. Suh, Robert G. Pendleton, Charles E. Pendley, II, Paul R. Menard, Alain B. Schreiber 1990-08-14
4861795 Treatment of conditions requiring enhanced oxygen availability to mammalian tissues John T. Suh, Robert G. Pendelton, Charles E. Pendley, II, Paul R. Menard, Alain B. Schreiber 1989-08-29
4849416 Treatment of conditions requiring enhanced oxygen availability to mammalian tissues Robert G. Pendleton, Charles E. Pendley, II, John T. Suh, Paul R. Menard, Tihamer Herczeg 1989-07-18